Crinetics Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CRNX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
22 Mar 24	SellUS$107,075	Jeff Knight	Individual	2,359	US$45.39
20 Mar 24	SellUS$31,195	Dana Pizzuti	Individual	714	US$43.69
28 Feb 24	BuyUS$20,000,022	Perceptive Advisors LLC	Company	476,191	US$42.00
15 Feb 24	SellUS$0	Perceptive Advisors LLC	Company	1,274,647	US$36.36
13 Jul 23	SellUS$1,010,317	R. Struthers	Individual	50,000	US$20.35
20 Jun 23	SellUS$218,003	Marc J. Wilson	Individual	10,922	US$19.96
16 Jun 23	SellUS$1,040,500	R. Struthers	Individual	50,000	US$20.81
08 Jun 23	BuyUS$110,300	Rogerio Coelho	Individual	5,000	US$22.06

Insider Buying: CRNX insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 44.6%.

Top 25 shareholders own 74.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.96%	T. Rowe Price Group, Inc.	5,426,351	US$235.7m	28.6%	0.02%
6.86%	BlackRock, Inc.	5,345,114	US$232.2m	10.3%	no data
6.47%	Driehaus Capital Management LLC	5,039,957	US$218.9m	-1.8%	1.72%
5.33%	EcoR1 Capital, LLC	4,155,375	US$180.5m	106%	5.75%
5.19%	FMR LLC	4,043,496	US$175.6m	88.9%	0.01%
4.57%	State Street Global Advisors, Inc.	3,563,736	US$154.8m	24.9%	0.01%
4.49%	The Vanguard Group, Inc.	3,502,452	US$152.1m	2.8%	no data
4.38%	Point72 Asset Management, L.P.	3,416,900	US$148.4m	-19.1%	0.32%
4.16%	Wellington Management Group LLP	3,245,105	US$141.0m	-10.9%	0.02%
3.27%	Jennison Associates LLC	2,547,683	US$110.7m	77.7%	0.07%
2.97%	Paradigm Biocapital Advisors LP	2,312,919	US$100.5m	6.16%	5.09%
2.55%	First Light Asset Management, LLC	1,987,772	US$86.3m	25.5%	8.09%
2.14%	OrbiMed Advisors LLC	1,667,360	US$72.4m	-42.4%	1.07%
1.89%	Perceptive Advisors LLC	1,476,203	US$64.1m	17.6%	1.49%
1.74%	Geode Capital Management, LLC	1,352,672	US$58.8m	6.54%	0.01%
1.48%	Cormorant Asset Management, LP	1,150,000	US$50.0m	4.36%	2.81%
1.41%	Novo Holdings A/S	1,100,000	US$47.8m	0%	0.03%
1.36%	Eventide Asset Management, LLC	1,059,633	US$46.0m	4.01%	0.79%
1.31%	R. Struthers	1,021,703	US$44.4m	3.66%	no data
1.01%	Saturn V Capital Management LP	787,132	US$34.2m	-30.1%	14.94%
1%	Lord, Abbett & Co. LLC	777,288	US$33.8m	6,600%	0.11%
0.92%	Medical Strategy GmbH, Asset Management Arm	715,862	US$31.1m	0.39%	1.9%
0.87%	Ikarian Capital, LLC	680,370	US$29.6m	-14.2%	7.54%
0.85%	Dimensional Fund Advisors LP	659,921	US$28.7m	-11.4%	0.01%
0.84%	BNPP Asset Management Holding	658,289	US$28.6m	3.94%	0.04%